跳至主要内容
临床试验/NCT05865054
NCT05865054招募中不适用

A Longitudinal Study of Orbital and Cranial Vessel Wall MRI in Giant Cell Arteritis by the Vascular MRI Evaluation in Giant Cell Arteritis (VEGA) Collaborative

University of Pennsylvania4 个研究点 分布在 3 个国家目标入组 400 人开始时间: 2020年7月29日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
400
试验地点
4
主要终点
Vessel Wall Enhancement Score

研究概览

简要总结

The research study is being conducted to determine the utility of magnetic resonance imaging (MRI) in identifying inflammation of arteries supplying blood to the head, brain, and eyes. The target population includes patient with suspected giant cell arteritis (GCA; temporal arteritis).

详细描述

After signing the consent form, participants will complete an MRI scan within 2 weeks of enrollment and fill out questionnaires related to their disease. Follow up visits and MRI scans may occur at 6-months after the initial MRI scan or at the time of relapse.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
50 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 50 years or older
  • First presentation of suspected GCA
  • New or worsening cranial manifestations within 4 weeks of enrollment concerning for active GCA
  • Elevated CRP greater than 1.0 mg/dl
  • Plan to undergo temporal artery biopsy or ultrasound for diagnosis

排除标准

  • Contra-indication to receiving MRI including:
  • Implanted medical devices, pacemaker, and metallic foreign fragments inside body/orbits Known gadolinium allergy Women who are pregnant or nursing
  • Absence of cranial symptoms related to GCA (e.g., only large vessel GCA)

结局指标

主要结局

Vessel Wall Enhancement Score

时间窗: Up to 12 months

Enhancement of cranial vessel wall, orbital structures, or other cranial structures. Scores range from 0 to 3; 0 being no inflammation and 3 being more enhancement or inflammation.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Rennie Rhee, M.D., MSCE

Assistant Professor of Medicine

University of Pennsylvania

研究点 (4)

Loading locations...

相似试验